Welcome to the forefront of conversational AI as we explore the fascinating world of AI chatbots in our dedicated blog series. Discover the latest advancements, applications, and strategies that propel the evolution of chatbot technology. From enhancing customer interactions to streamlining business processes, these articles delve into the innovative ways artificial intelligence is shaping the landscape of automated conversational agents. Whether you’re a business owner, developer, or simply intrigued by the future of interactive technology, join us on this journey to unravel the transformative power and endless possibilities of AI chatbots.
ADVERTISEMENT
The growing role of artificial intelligence in everyday life is now colliding with the legal system in a deeply troubling way. OpenAI and its chief executive Sam Altman are facing a lawsuit from the parents of a 19-year-old American who died from an accidental overdose after allegedly receiving dangerous drug-related guidance from ChatGPT.
Filed in California, the lawsuit claims the chatbot acted less like a search tool and more like a highly personalised adviser, offering recommendations on drug combinations and responding in a tone that appeared authoritative and medically credible.
The case centres on Sam Nelson, who, according to court filings, frequently interacted with ChatGPT while experimenting with substances including kratom, Xanax and alcohol. His parents, Leila Turner-Scott and Angus Scott, allege that the AI system suggested ways to manage the effects of certain drugs and continued providing guidance despite indications of risky behaviour.
Also read: Google in talks with Centre, West Bengal for major tech hub as India’s AI push accelerates – Storyboard18
Kratom, a herbal substance known for producing opioid-like effects, reportedly became a recurring topic in Nelson’s conversations with the chatbot. The lawsuit alleges that after Nelson complained of nausea linked to kratom use, ChatGPT suggested Xanax as a possible remedy. The combination of Xanax, kratom and alcohol later proved fatal.
Nelson died in May 2025 from what the lawsuit describes as an accidental overdose.
At the heart of the complaint is the claim that newer versions of ChatGPT became significantly more conversational and personalised after the rollout of GPT-4o in 2024. According to the filing, earlier versions of the chatbot often refused to answer drug-related questions or displayed strong warnings about harmful substances. However, the lawsuit alleges that later iterations began providing more detailed responses involving drug interactions, dosing information and even discussions around sourcing substances.
The parents also argue that ChatGPT’s memory features allowed the system to retain details about Nelson’s previous substance use, making future responses increasingly tailored to his behaviour and vulnerabilities.
The lawsuit accuses OpenAI of prioritising rapid product development amid intensifying competition in the AI industry without conducting sufficient safety testing for high-risk conversations involving health, addiction and substance abuse.
Also read: Supreme Court likely to hear petitions challenging India’s Digital Personal Data Protection Act and RTI changes – Storyboard18
The company has responded by saying the interactions referenced in the case involved an older version of ChatGPT that is no longer available. OpenAI spokesperson Drew Pusateri described the incident as “heartbreaking” and said the company continues improving safeguards designed to detect dangerous requests and redirect users towards professional help.
Still, the case adds to a growing wave of legal challenges confronting AI companies worldwide. In recent months, lawsuits involving AI chatbots have raised concerns over self-harm advice, emotional dependency, violent behaviour and manipulation. Courts are increasingly being asked to determine whether conversational AI systems should be treated as neutral tools or held accountable when their responses contribute to real-world harm.
The latest lawsuit also seeks to temporarily block the rollout of ChatGPT Health, a healthcare-focused OpenAI platform that allows users to upload medical records and receive AI-generated guidance. OpenAI has previously stated that millions of users already turn to ChatGPT daily for health-related questions.
ADVERTISEMENT
As the creator economy explodes, influencer marketing agencies are emerging as the real power brokers reshaping how corporate India spends its advertising money.
ADVERTISEMENT
Storyboard18 Awards for Creativity 2026 honoured campaigns that blended storytelling, cultural relevance and measurable impact across platforms.
ADVERTISEMENT
Brand Marketing
Storyboard18 Creativity Awards 2026: Swiggy, Nestlé, HDFC, Flipkart, Puma, Lahori Zeera take center stage
Brand Makers
Key takeaways from Global Pioneers Summit 2026: Why trust, storytelling and attention will define India’s next decade
Brand Makers
From Flipkart to Swiggy, winners of Storyboard18 Awards 2026: See photos (Part 1)
Brand Makers
Storyboard18 Awards 2026 winners in pics: Fevicol, KitKat, Swiggy (Part 2)
Special Coverage
SAC 2026: Why Piyush Pandey remains the North Star for India’s evolving creative landscape
Trending News
ChatGPT Image 2.0 can fix LinkedIn’s ‘good photo’ problem in seconds, says Anupam Mittal
Brand Makers
OpenAI taps WPL, regional creators and farmers to mainstream AI in India: Sheeladitya Mohanty
Trending News
ChatGPT cracks 60-year-old math puzzle humans couldn’t solve
Brand Marketing
ChatGPT users in India can now access job listings via Indeed
Brand Makers
Google CEO Sundar Pichai says company was ready for AI shift with in-house chips and infrastructure
